Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEEL
2451
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $1.5M | ﹤0.01% |
291
+28
| +11% | +$107K |
|
2452
MeiraGTx Holdings
MGTX
$1.27B
| $1.5M | ﹤0.01% |
74,830
-44,842
| -37% | -$767K |
|
2453
Construction Partners
ROAD
$6.96B
| $1.5M | ﹤0.01% |
88,700
-141,100
| -61% | -$2.48M |
|
2454
ProShares Ultra Dow30
DDM
$542M
| $1.5M | ﹤0.01% |
+53,800
| New | +$1.4M |
|
|
JCTC
2455
Jewett-Cameron Trading
JCTC
$10.2M
| $1.49M | ﹤0.01% |
193,475
+1,000
| +0.5% | +$7.87K |
|
|
AGS
2456
DELISTED
PlayAGS
AGS
| $1.49M | ﹤0.01% |
+122,700
| New | +$1.4M |
|
2457
Network-1 Technologies
NTIP
$35.4M
| $1.49M | ﹤0.01% |
681,616
+3,300
| +0.5% | +$7.28K |
|
|
CNR
2458
Core Natural Resources Inc
CNR
$4.78B
| $1.49M | ﹤0.01% |
102,442
-268,458
| -72% | -$3.71M |
|
|
RNWK
2459
DELISTED
RealNetworks Inc
RNWK
| $1.49M | ﹤0.01% |
1,237,643
+19,204
| +2% | +$27.6K |
|
2460
BJs Wholesale Club
BJ
$12B
| $1.48M | ﹤0.01% |
65,168
-355,432
| -85% | -$8.79M |
|
2461
Ampco-Pittsburgh
AP
$195M
| $1.48M | ﹤0.01% |
491,124
+2,100
| +0.4% | +$7.42K |
|
|
BOCH
2462
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $1.47M | ﹤0.01% |
127,047
-2,753
| -2% | -$31.1K |
|
2463
1-800-Flowers.com
FLWS
$258M
| $1.47M | ﹤0.01% |
101,000
+73,600
| +269% | +$1M |
|
2464
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.76B
| $1.46M | ﹤0.01% |
+30,564
| New | +$1.4M |
|
|
WTT
2465
DELISTED
Wireless Telecom Group, Inc.
WTT
| $1.46M | ﹤0.01% |
1,022,383
+8,500
| +0.8% | +$11.9K |
|
|
LOAN
2466
Manhattan Bridge Capital
LOAN
$47.1M
| $1.45M | ﹤0.01% |
228,062
+31,000
| +16% | +$195K |
|
2467
Origin Bancorp
OBK
$1.68B
| $1.45M | ﹤0.01% |
38,300
-16,300
| -30% | -$571K |
|
|
RTW
2468
DELISTED
RTW Retailwinds, Inc.
RTW
| $1.45M | ﹤0.01% |
1,808,358
+84,000
| +5% | +$106K |
|
2469
China Automotive Systems
CAAS
$141M
| $1.43M | ﹤0.01% |
454,410
+104,319
| +30% | +$274K |
|
2470
W.P. Carey
WPC
$16.3B
| $1.43M | ﹤0.01% |
+18,252
| New | +$1.53M |
|
|
BCLI
2471
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $1.43M | ﹤0.01% |
22,262
+2,453
| +12% | +$142K |
|
|
CSS
2472
DELISTED
CSS Industries, Inc.
CSS
| $1.43M | ﹤0.01% |
324,019
+24,900
| +8% | +$112K |
|
|
NBRV
2473
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $1.43M | ﹤0.01% |
4,319
-1,198
| -22% | -$549K |
|
|
AINC
2474
DELISTED
Ashford Inc.
AINC
| $1.42M | ﹤0.01% |
60,252
+24,277
| +67% | +$578K |
|
2475
Danaos Corp
DAC
$2.58B
| $1.42M | ﹤0.01% |
154,552
+93,021
| +151% | +$898K |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.